Faculty:

Collaborations:

Clinical Staff:

Clinical Research Staff:

  • Marian A. Perez, AA, CCRC
  • Monica Quesada
  • Wendy Levy

Directions to NPF Building

Movement Disorders

The Center for Parkinson’s Disease and Movement Disorders (the "Center") is a division of the Department of Neurology within the Leonard M. Miller School of Medicine (MSM) of the University of Miami (UM).  The Center was started in 1984 and has been under the direction of Dr. Carlos Singer since 2002.  It employs four clinical faculty, one Advance Registered Nurse Practitioner, one Licensed Clinical Social Worker, and a support staff of eight.  The Center received the designation as a Center of Excellence from the National Parkinson’s Foundation in 2007. From the time of its inception, the Center’s mission has included patient care, research, education and community outreach. The Center’s core philosophy is patient and caregiver centered. In the area of education, the center emphasizes the values of patient and compassion, a holistic approach to medical care and provision to future health professionals of the basic clinical skills to care for patients with Parkinson’s disease. The Center serves as a tertiary referral center for patients suffering from Parkinson’s disease and other movement disorders in the South Florida community. The Center is also the premier referral center for patients from abroad with a singular projection to Latin America and the Caribbean.

Services Provided:

The Center for Parkinson's Disease and Movement Disorders provides the following services:
  • Specialized medical diagnosis and treatment of Parkinson’s disease and other movement disorders.
  • State of the art neurosurgical therapies including deep brain stimulation for Parkinson’s disease and other movement disorders.
  • Opportunity to participate in research including clinical trials, genetic studies and neuroimaging.
  • Clinical social work case management services.
  • Inpatient consultation services at Jackson Memorial Hospital and Medical Center and the University of Miami Hospital and Clinics.
  • Interdisciplinary Clinic in partnership with St. Catherine’s Rehabilitation Center for patients with Parkinson’s disease. The team consists of a social worker, physiotherapist, occupational therapist, speech therapist and a physician and/or advance registered nurse practitioner. 
  • Community outreach activities including support groups, wellness and exercise sessions, educational seminars for patients, families and health professionals.

Faculty Clinical Research Focus:

  1. Carlos Singer, MD – Nonmotor aspects of Parkinson’s disease.
  2. Bruno V. Gallo, MD – Electrophysiology and neuro-stimulation.
  3. Fatta B. Nahab, MD –  Neuroimaging of movement disorders
  4. Cenk Sengun. MD – Community outreach and patient education.

Links and Publications:

 

Faculty Photo

 

From left to right: Jonathan Jagid M.D.,  Bruno V. Gallo M.D.,
Carlos Singer M.D.,  Cenk Sengun M.D.

    
       
Movement Disorder Studies
Study Description Enrollment Status
 
STEADY-PD Isradipine vs placebo in the treatment of patients with early, treated Parkinson's Disease Enrolling
QE3 Coenzyme Q10 vs placebo in the treatment of patients with early, untreated Parkinson's Disease Enrolling
NET-PD LS-1 Creatine vs placebo in the treatment of patients with early, treated Parkinson's Disease Enrolling
Rotigotine (Neupro®) vs placebo (SP921) Rotigotine (Neupro®) vs placebo in patients with advanced-stage Parkinson’s disease Enrolling
URGE-PD Vesicare vs placebo in the treatment of urinary frequency in patients with Parkinson’s Disease Enrollment pending
Pramipexole IR vs Ropinirole (BIPI) Pramipexole IR vs Ropinirole in patients with early Parkinson's Disease Not enrolling
ANS Deep Brain Stimulator (DBS) surgical study Not enrolling
TEVA 501 Open label study on the long-term effects of rasagiline in patients with Parkinson’s Disease participated in the ADAGIO study Not enrolling
COHORT Cooperative Huntington Observational Research Trial to study the genetics and environmental factors of Huntington's Disease Enrolling
2CARE [Coenzyme Q10 (CoQ)] Coenzyme Q10 vs placebo in the treatment of early-stage Huntington's Disease Enrolling
HORIZON Dimebon vs placebo in the treatment of mild to moderate dementia in patients with Huntington's Disease Enrolling
CD-PROBE Informational study for patients with Cervical Dystonia new to the study physician’s practice or new to botulinum toxin Enrolling